• CONTACT
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • About Us
    • Message From CEO
    • Mission/Vision
    • Management Team
    • Company Milestones
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial

US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System

by PVA_Admin | May 7, 2024 | 2024 press Release, Press Release

US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™...

Recent Posts

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
  • The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer
  • USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations